Cook Medical’s New Bipolar Electrodes Portfolio Includes the Most In-Demand Configurations

Cook Medical has launched a new, streamlined portfolio of urological bipolar electrodes in the U.S. This portfolio includes the products that urologists use most frequently to focus on daily electrode needs when performing procedures on the bladder and prostate.

The bipolar electrodes portfolio includes a total of seven products.1 The portfolio is streamlined to include the most frequently used and in-demand products in this category. Six of the products are configurations indicated for use in transurethral resection, ablation and soft tissue removal of the prostate and bladder and where hemostasis is required:

  • A bipolar transurethral bladder loop, which is angled at 136° to accommodate the anatomy of the bladder
  • Four transurethral cutting loops—12° and 30° options, each available in medium and large sizes
  • A bipolar transurethral needle electrode

The seventh product is the Bipolar Transurethral Plasma Disc®, which is made for electro-vaporization in urological procedures to help with vaporization of the prostate and coagulation. The patented concentric, multi-tiered disc design by Omnitech Systems, Inc., provides concentrated current density to be more energy efficient while still supporting current flow and plasma ignition.2

The distal wires of each electrode tip (except for the transurethral needle electrode) are made from a platinum-iridium alloy, which extends from the leading edge past the stabilizer. The platinum-iridium alloy is reinforced by being crimped deep into the body of the electrode for durability. The electrodes have a shelf life of five years, providing additional stock and supply benefits.

“We listened to physicians about obstacles they were facing when trying to perform resection and ablation procedures, such as benign prostatic hyperplasia (BPH). For example, we learned that most bladder loops on the market were difficult to use around the bladder, so we offer a bladder loop angled at 136° to improve efficiency of surgery. With the seven products in the streamlined bipolar electrodes portfolio, we aim to help physicians focus on treating patients with products they use frequently,” said Rob Faulkner, senior director of Cook Medical’s Urology specialty.

For a product brochure and to learn more about Cook’s bipolar electrodes products, visit the product information page.

Plasma Disc is a registered trademark of Omnitech Systems, Inc.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version